Active substance
Results for the substance lopinavir ritonavir
12 results
About this active substance
- Lopinavir is the main active agent that inhibits HIV protease, an enzyme essential for viral replication.
- Ritonavir is used in low doses to boost lopinavir levels in the blood by inhibiting its metabolism in the liver (boosting effect).
This combination is administered as tablets or oral solution, usually twice daily, in combination with other antiretroviral drugs as part of highly active antiretroviral therapy (HAART).
Side effects may include nausea, diarrhea, abdominal pain, fatigue, increased cholesterol and triglyceride levels, and changes in liver function. In rare cases, it may cause pancreatitis or severe allergic reactions. It is important to take the medication as prescribed by a doctor, and patients should be regularly monitored to assess treatment effectiveness and prevent adverse effects.
-
-
KALETRA 200mg/50mg film-coated tablets ABBVIE ORIGINAL MEDICINE
-
LOPINAVIR/RITONAVIR MYLAN 200mg/50mg film-coated tablets
-
LOPINAVIR/RITONAVIR VIATRIS 200mg/50mg film-coated tablets VIATRIS LIMITED
-
LOPINAVIR/RITONAVIR VIATRIS 100mg/25mg film-coated tablets VIATRIS LIMITED
-
LOPINAVIR/RITONAVIR ACCORD 200mg/50mg film-coated tablets
-
LOPINAVIR AND RITONAVIR TABLETS USP 200mg/50mg film-coated tablets UNIFARM
-
LOPINAVIR/RITONAVIR MYLAN 100mg/25mg film-coated tablets
-
LOPINAVIR/RITONAVIR SANDOZ 200mg/50mg film-coated tablets
-
LOPINAVIR/RITONAVIR TERAPIA 200mg/50mg film-coated tablets
-
KALETRA 133.3mg/33.3mg soft capsules ABBVIE ORIGINAL MEDICINE
Chemical substance: lopinavir + ritonavir
ATC code: J05AE06 • Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
-
KALETRA 100mg/25mg film-coated tablets ABBVIE ORIGINAL MEDICINE
Chemical substance: lopinavir + ritonavir
ATC code: J05AE06 • Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors